norepinephrine bitartrate in 0.9% sodium chloride Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Norepinephrine Bitartrate In 0.9% Sodium Chloride, and what generic alternatives are available?

Norepinephrine Bitartrate In 0.9% Sodium Chloride is a drug marketed by Inforlife and Long Grove Pharms and is included in two NDAs. There are seven patents protecting this drug.

This drug has three patent family members in two countries.

The generic ingredient in NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE is norepinephrine bitartrate. There are five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Norepinephrine Bitartrate In 0.9% Sodium Chloride

A generic version of norepinephrine bitartrate in 0.9% sodium chloride was approved as norepinephrine bitartrate by MEITHEAL on March 3^rd, 2003.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for norepinephrine bitartrate in 0.9% sodium chloride?
What are the global sales for norepinephrine bitartrate in 0.9% sodium chloride?
What is Average Wholesale Price for norepinephrine bitartrate in 0.9% sodium chloride?

Summary for norepinephrine bitartrate in 0.9% sodium chloride

International Patents:	3
US Patents:	7
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	2
Clinical Trials:	9
DailyMed Link:	norepinephrine bitartrate in 0.9% sodium chloride at DailyMed

Drug patent expirations by year for norepinephrine bitartrate in 0.9% sodium chloride

Recent Clinical Trials for norepinephrine bitartrate in 0.9% sodium chloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Alberta	Phase 4
Tunis University	Phase 4
Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A

See all norepinephrine bitartrate in 0.9% sodium chloride clinical trials

Pharmacology for norepinephrine bitartrate in 0.9% sodium chloride

Drug Class	Catecholamine

US Patents and Regulatory Information for norepinephrine bitartrate in 0.9% sodium chloride

norepinephrine bitartrate in 0.9% sodium chloride is protected by seven US patents.

Patents protecting norepinephrine bitartrate in 0.9% sodium chloride

Norepinephrine compositions and methods therefor
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Norepinephrine compositions and methods therefor
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: INDICATED TO RAISE BLOOD PRESSURE IN ADULT PATIENTS WITH SEVERE, ACUTE HYPOTENSION

Norepinephrine compositions and methods therefor
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: INDICATED TO RAISE BLOOD PRESSURE IN ADULT PATIENTS WITH SEVERE, ACUTE HYPOTENSION

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Inforlife	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	215700-001	Sep 15, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Long Grove Pharms	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214628-003	Oct 6, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Long Grove Pharms	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214628-001	Oct 6, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Long Grove Pharms	NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	norepinephrine bitartrate	SOLUTION;INTRAVENOUS	214628-001	Oct 6, 2022		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for norepinephrine bitartrate in 0.9% sodium chloride

See the table below for patents covering norepinephrine bitartrate in 0.9% sodium chloride around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	3051467	COMPOSITIONS DE NOREPINEPHRINE ET PROCEDES ASSOCIES (NOREPINEPHRINE COMPOSITIONS AND METHODS THEREFOR)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2020217079		⤷ Sign Up
World Intellectual Property Organization (WIPO)	2018140894		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration